These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 31445394)

  • 21. CRISPR/Cas9-mediated editing of ACTB in induced pluripotent stem cells: A model for investigating human ACTB loss-of-function and genetic adaptive responses.
    Binder S; Ramachandran H; Haslinger D; Hildebrandt B; Dobner J; Haarmann-Stemmann T; Chiocchetti A; Rossi A
    Stem Cell Res; 2024 Jun; 77():103395. PubMed ID: 38518401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of a TRPV1 knockout human pluripotent stem cell line (WAe009-A-U) using CRISPR/Cas9.
    Cao Y; Tang L; Su J; Wang H; Liang P; Rong K; Gong T
    Stem Cell Res; 2023 Oct; 72():103202. PubMed ID: 37708613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of a CAG-EGFP tagged cell line (KSCBi017-A-2) from human induced pluripotent stem cells using CRISPR/Cas9.
    Han HW; Im YS; Kim YO; Kwak S; Cho SJ
    Stem Cell Res; 2024 Mar; 75():103303. PubMed ID: 38211411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of a TBX20 homozygous knockout stem cell line (WAe009-A-1E) by episomal vector-based CRISPR/Cas9 system.
    Hou X; Mu J
    Stem Cell Res; 2024 Jun; 77():103384. PubMed ID: 38479330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of MBP-tdTomato reporter human induced pluripotent stem cell line for live myelin visualization.
    Takagi D; Tsukamoto S; Nakade K; Shimizu T; Arai Y; Matsuo-Takasaki M; Noguchi M; Nakamura Y; Yumoto N; Kawada J; Hayata T; Hayashi Y
    Stem Cell Res; 2024 Sep; 79():103493. PubMed ID: 39032428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of isogenic and homozygous MEN1 mutant cell lines from patient-derived iPSCs using CRISPR/Cas9.
    Even-Zohar N; Metin-Armagan D; Ben-Shlomo A; Sareen D; Melmed S
    Stem Cell Res; 2023 Jun; 69():103124. PubMed ID: 37209468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of a human TLR4 compound heterozygous knockout hESC line (WAe009-A-N) to model toll-like receptor 4 deficiency by CRISPR/Cas9 system.
    Ruan Y; Tian X; Li X; Zhang Y
    Stem Cell Res; 2023 Dec; 73():103225. PubMed ID: 37931537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of a NONO homozygous knockout human induced pluripotent stem cell line by CRISPR/Cas9 editing.
    Yi T; Bai R; Sun H; Lan F; Zhang H; He Y
    Stem Cell Res; 2020 Jul; 47():101893. PubMed ID: 32717574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of a TLR2 knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Kim JH
    Stem Cell Res; 2021 Dec; 57():102578. PubMed ID: 34710836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of a homozygous S100A1 knockout human embryonic stem cell line (WAe009-A-73) by the CRISPR/Cas9 editing system.
    Zhang S; Guo T; Song Y; Jiang M; Jiang Y; Dong T; Zhang S; Wang H; Hou X
    Stem Cell Res; 2022 Mar; 59():102631. PubMed ID: 34953326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of a homozygous CIITA knockout iPS cell line using the CRISPR-Cas9 system.
    Romano E; Trionfini P; Giampietro R; Benigni A; Tomasoni S
    Stem Cell Res; 2021 Dec; 57():102580. PubMed ID: 34688128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of SHMT2 knockout human embryonic stem cell line (WAe009-A-67) using CRISPR/Cas9 technique.
    Li J; Zhang B; Gan M; Li Y; He L; Yue W; Qiao H; Pei X; Li Y
    Stem Cell Res; 2021 Dec; 57():102581. PubMed ID: 34688993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining the Teratoma as a Model for Multi-lineage Human Development.
    McDonald D; Wu Y; Dailamy A; Tat J; Parekh U; Zhao D; Hu M; Tipps A; Zhang K; Mali P
    Cell; 2020 Nov; 183(5):1402-1419.e18. PubMed ID: 33152263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of two RNF2 homozygous knockout human embryonic stem cell lines by CRISPR/Cas9 system.
    Shan Y; Ma L; Zhang C; Zhang Y; Zhang J; Xiao L; Wei Y; Yu Y
    Stem Cell Res; 2020 Jun; 47():101885. PubMed ID: 32610219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of green fluorescent protein reporter knock-in iPSC line at the 3'UTR region of the KLOTHO locus.
    Lim SW; Lee KI; Cui S; Fang X; Shin YJ; Lee H; Lee JY; Chung BH; Yang CW
    Stem Cell Res; 2024 Oct; 80():103499. PubMed ID: 39111000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of a DKK2 homozygous knockout human embryonic stem cell line using the CRISPR/Cas9 system.
    Zhang W; Li Y; Wang L; Xin T; Zhang C
    Stem Cell Res; 2021 Dec; 57():102611. PubMed ID: 34856466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of a homozygous COX6A2 knockout human embryonic stem cell line (WAe009-A-47) via an epiCRISPR/Cas9 system.
    Hang C; Song Y; Wu F; Dong T; Jiang M; Saleem A; Zhang S; Chang Y; Lu W; Cui M
    Stem Cell Res; 2021 Jan; 50():102152. PubMed ID: 33418201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of a human iPSC line harboring a biallelic large deletion at the INK4 locus (HMGUi001-A-5).
    Shahryari A; Moya N; Siehler J; Wang X; Karolina Blöchinger A; Burtscher I; Bakhti M; Mowla SJ; Lickert H
    Stem Cell Res; 2020 Jul; 47():101927. PubMed ID: 32739881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of a miR-26b stem-loop knockout human iPSC line, MCRIi019-A-1, using CRISPR/Cas9 editing.
    Kung LHW; Sampurno L; Little CB; Lamandé SR; Bateman JF
    Stem Cell Res; 2020 Dec; 50():102118. PubMed ID: 33316599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of a COL1A2 homozygous knockout stem cell line via CRISPR/Cas9 system.
    Ma S; Saleem A; Li X; Lu WJ; Jiang H
    Stem Cell Res; 2022 Mar; 59():102652. PubMed ID: 34999419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.